Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07586241 · ClinicalTrials.gov registry record
Vascular Endothelial Inflammation and Health Status In INOCA (VISION-INOCA)
A clinical trial, sponsored by NYU Langone Health.
- Not yet
- Registry status
- 250
- Enrollment target
NCT07586241 is a clinical trial that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 250 participants.
The verdict
NCT07586241 has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate coronary artery and peripheral vein vascular endothelial profiles in patients with ischemia with non-obstructive coronary arteries (INOCA) who undergo coronary function testing (CFT). The aims are: (1) Evaluate coronary artery endothelial profiles and associations with coronary microvascular dysfunction (CMD) in INOCA. (2) Assess brachial vein endothelial cell profiles in patients with INOCA and associations with CMD, and (3) Characterize relationships between endothelial signatures and anginal symptoms, functional status, and physical activity at baseline and 1-year follow-up.
Interventions
- DEVICE Fitbit
- PROCEDURE Invasive coronary angiography
- PROCEDURE Coronary Artery Endothelial Cell Sampling
- DIAGNOSTIC_TEST Invasive coronary function testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2026-05 |
| Est. Completion | 2031-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07586241
The ClinicalTrials.gov registry entry for NCT07586241 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Fitbit is the first listed.
NCT07586241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07586241 about?
NCT07586241 is a clinical study titled "Vascular Endothelial Inflammation and Health Status In INOCA (VISION-INOCA)". The purpose of this study is to evaluate coronary artery and peripheral vein vascular endothelial profiles in patients with ischemia with non-obstructive coronary arteries (INOCA) who undergo coronary function testing (CFT). The aims are: (1) Evaluate coronary artery endothelial profiles and associa...
What is the current status of trial NCT07586241?
This trial is currently not yet recruiting. The enrollment target is 250 participants. The study started on 2026-05. Estimated completion is 2031-03-01.
What interventions are being tested in trial NCT07586241?
The interventions under investigation include: Fitbit (DEVICE), Invasive coronary angiography (PROCEDURE), Coronary Artery Endothelial Cell Sampling (PROCEDURE), Invasive coronary function testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07586241?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.